Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases

Bone is the most common site of prostate cancer (PCa) progression to a therapy-resistant, lethal phenotype. We found that blockade of fibroblast growth factor receptors (FGFRs) with the receptor tyrosine kinase inhibitor dovitinib has clinical activity in a subset of men with castration-resistant PC...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wan, X., Corn, P.G., Yang, J., Palanisamy, N., Starbuck, M.W., Efstathiou, E., Li-Ning Tapia, E.M., Zurita, A.J., Aparicio, A., Ravoori, M.K., Vazquez, E.S., Robinson, D.R., Wu, Y.-M., Cao, X., Iyer, M.K., McKeehan, W., Kundra, V., Wang, F., Troncoso, P., Chinnaiyan, A.M., Logothetis, C.J., Navone, N.M.
Formato: JOUR
Materias:
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_19466234_v6_n252_p_Wan
Aporte de:

Ejemplares similares